[1]
S. Shahrabi, A. Ehsanpour, S. Heidary, M. Shahjahani, and M. Maleki Behzad, “Expression of CD markers in JAK2V617F positive myeloproliferative neoplasms: Prognostic significance”, Oncology Reviews, vol. 12, no. 2, Oct. 2018.